Jan 9 (Reuters) - Delmar Pharmaceuticals Inc DMPI.O
* Delmar pharmaceuticals receives additional non-dilutive funding from government of canada to support expanded research with lead product candidate val-083 Source text for Eikon: ID:nPn7rN0sda Further company coverage: DMPI.O